CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/facility

facility organization

Max Planck Institute of Psychiatry

DE

OPENALEX: I4210145969↗ROR: 04dq56617↗

People

Connected researchers

Beat LutzORCID 0000-0002-1062-6889 Carsten T. WotjakORCID 0000-0002-2159-5379 D CotaORCID 0000-0002-6909-2156 Giovanni MarsicanoORCID 0000-0003-3804-1951 Hans‐Ulrich WïttchenORCID 0000-0002-6311-7711 Jim van OsORCID 0000-0002-7245-1586 Nikolaos KoutsoulerisORCID 0000-0001-6825-6262 Paul M. KaplickORCID 0000-0003-3252-2279 Peter FalkaiORCID 0000-0003-2873-8667 Rachele SanfeliciORCID 0000-0002-1674-9708 Rimas A. KubiliusExact authorship link Sebastian von SaldernExact authorship link Tibor StarkORCID 0000-0001-8118-9914

Public evidence

2 connected articles

Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.2021 · PubMed Central Open Access Highway to hell or magic smoke? The dose-dependence of Δ<sup>9</sup>-THC in place conditioning paradigms.2018 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.

Max Planck Institute of Psychiatry - Medical Cannabis Research Engine